What new Dupilumab data suggest about long-term immune control in allergic disease at Regeneron Pharmaceuticals
Ryerson Holding (NYSE: RYI) finalises Olympic Steel acquisition as North American metals consolidation accelerates
Read More 5 minute read Pharma Industry News Island Pharmaceuticals (ASX: ILA) awaits FDA clearance for Galidesivir as Animal Rule review enters final phase Island Pharmaceuticals confirms no FDA setbacks on Galidesivir. Find out what this means for its Marburg virus study and broader regulatory strategy. bySrinathJanuary 6, 2026